nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP3A4—prostate cancer	0.237	1	CbGaD
Ranolazine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0697	0.154	CbGbCtD
Ranolazine—CYP2D6—Bicalutamide—prostate cancer	0.0576	0.128	CbGbCtD
Ranolazine—CYP2D6—Abiraterone—prostate cancer	0.0477	0.106	CbGbCtD
Ranolazine—CYP3A4—Bicalutamide—prostate cancer	0.0366	0.0811	CbGbCtD
Ranolazine—CYP3A4—Estramustine—prostate cancer	0.034	0.0754	CbGbCtD
Ranolazine—CYP3A4—Abiraterone—prostate cancer	0.0303	0.0672	CbGbCtD
Ranolazine—CYP3A4—Flutamide—prostate cancer	0.0303	0.0672	CbGbCtD
Ranolazine—CYP3A4—Cabazitaxel—prostate cancer	0.0224	0.0497	CbGbCtD
Ranolazine—CYP3A4—Estrone—prostate cancer	0.0219	0.0486	CbGbCtD
Ranolazine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0196	0.0433	CbGbCtD
Ranolazine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0144	0.0318	CbGbCtD
Ranolazine—CYP3A4—Mitoxantrone—prostate cancer	0.013	0.0289	CbGbCtD
Ranolazine—CYP3A4—Estradiol—prostate cancer	0.0126	0.0279	CbGbCtD
Ranolazine—CYP3A4—Prednisone—prostate cancer	0.0108	0.024	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—prostate cancer	0.00883	0.0196	CbGbCtD
Ranolazine—CYP3A4—Etoposide—prostate cancer	0.00823	0.0182	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—prostate cancer	0.00753	0.0167	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—prostate cancer	0.00561	0.0124	CbGbCtD
Ranolazine—Carvedilol—GJA1—prostate cancer	0.00116	0.224	CrCbGaD
Ranolazine—Carvedilol—HIF1A—prostate cancer	0.000881	0.17	CrCbGaD
Ranolazine—Bevantolol—ADRB2—prostate cancer	0.000437	0.0843	CrCbGaD
Ranolazine—Carvedilol—VEGFA—prostate cancer	0.000355	0.0684	CrCbGaD
Ranolazine—Bupivacaine—CYP2C19—prostate cancer	0.000342	0.0659	CrCbGaD
Ranolazine—Levobupivacaine—CYP3A4—prostate cancer	0.000272	0.0524	CrCbGaD
Ranolazine—Bupivacaine—CYP3A4—prostate cancer	0.000217	0.0419	CrCbGaD
Ranolazine—Carvedilol—ADRB2—prostate cancer	0.0002	0.0385	CrCbGaD
Ranolazine—Propranolol—CYP3A5—prostate cancer	0.000192	0.0371	CrCbGaD
Ranolazine—Ropivacaine—CYP3A4—prostate cancer	0.000175	0.0338	CrCbGaD
Ranolazine—Carvedilol—CYP2E1—prostate cancer	0.000174	0.0335	CrCbGaD
Ranolazine—Carvedilol—CYP1A1—prostate cancer	0.000171	0.033	CrCbGaD
Ranolazine—Propranolol—ADRB2—prostate cancer	0.000152	0.0293	CrCbGaD
Ranolazine—Propranolol—CYP2C19—prostate cancer	0.000131	0.0252	CrCbGaD
Ranolazine—Propranolol—CYP1A1—prostate cancer	0.00013	0.0251	CrCbGaD
Ranolazine—Carvedilol—CYP3A4—prostate cancer	0.000109	0.0211	CrCbGaD
Ranolazine—Dyspnoea—Etoposide—prostate cancer	9.89e-05	0.000428	CcSEcCtD
Ranolazine—Somnolence—Etoposide—prostate cancer	9.86e-05	0.000427	CcSEcCtD
Ranolazine—Cough—Docetaxel—prostate cancer	9.86e-05	0.000426	CcSEcCtD
Ranolazine—Vertigo—Capecitabine—prostate cancer	9.83e-05	0.000425	CcSEcCtD
Ranolazine—Syncope—Capecitabine—prostate cancer	9.81e-05	0.000424	CcSEcCtD
Ranolazine—Mental disorder—Prednisone—prostate cancer	9.81e-05	0.000424	CcSEcCtD
Ranolazine—Leukopenia—Capecitabine—prostate cancer	9.79e-05	0.000423	CcSEcCtD
Ranolazine—Malnutrition—Prednisone—prostate cancer	9.74e-05	0.000421	CcSEcCtD
Ranolazine—Palpitations—Capecitabine—prostate cancer	9.67e-05	0.000418	CcSEcCtD
Ranolazine—Decreased appetite—Etoposide—prostate cancer	9.65e-05	0.000417	CcSEcCtD
Ranolazine—Loss of consciousness—Capecitabine—prostate cancer	9.62e-05	0.000416	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—prostate cancer	9.61e-05	0.000416	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—prostate cancer	9.59e-05	0.000415	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Etoposide—prostate cancer	9.58e-05	0.000414	CcSEcCtD
Ranolazine—Asthenia—Mitoxantrone—prostate cancer	9.57e-05	0.000414	CcSEcCtD
Ranolazine—Fatigue—Etoposide—prostate cancer	9.57e-05	0.000414	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.55e-05	0.000413	CcSEcCtD
Ranolazine—Cough—Capecitabine—prostate cancer	9.55e-05	0.000413	CcSEcCtD
Ranolazine—Constipation—Etoposide—prostate cancer	9.49e-05	0.00041	CcSEcCtD
Ranolazine—Dizziness—Estradiol—prostate cancer	9.47e-05	0.000409	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—prostate cancer	9.46e-05	0.000409	CcSEcCtD
Ranolazine—Dry mouth—Docetaxel—prostate cancer	9.41e-05	0.000407	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—prostate cancer	9.3e-05	0.000402	CcSEcCtD
Ranolazine—Confusional state—Docetaxel—prostate cancer	9.3e-05	0.000402	CcSEcCtD
Ranolazine—Anxiety—Capecitabine—prostate cancer	9.28e-05	0.000401	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.25e-05	0.0004	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—prostate cancer	9.2e-05	0.000398	CcSEcCtD
Ranolazine—Vision blurred—Prednisone—prostate cancer	9.18e-05	0.000397	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—prostate cancer	9.16e-05	0.000396	CcSEcCtD
Ranolazine—Feeling abnormal—Etoposide—prostate cancer	9.14e-05	0.000395	CcSEcCtD
Ranolazine—Dry mouth—Capecitabine—prostate cancer	9.11e-05	0.000394	CcSEcCtD
Ranolazine—Vomiting—Estradiol—prostate cancer	9.1e-05	0.000394	CcSEcCtD
Ranolazine—Gastrointestinal pain—Etoposide—prostate cancer	9.07e-05	0.000392	CcSEcCtD
Ranolazine—Shock—Docetaxel—prostate cancer	9.07e-05	0.000392	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—prostate cancer	9.04e-05	0.000391	CcSEcCtD
Ranolazine—Thrombocytopenia—Docetaxel—prostate cancer	9.03e-05	0.00039	CcSEcCtD
Ranolazine—Rash—Estradiol—prostate cancer	9.03e-05	0.00039	CcSEcCtD
Ranolazine—Dermatitis—Estradiol—prostate cancer	9.02e-05	0.00039	CcSEcCtD
Ranolazine—Confusional state—Capecitabine—prostate cancer	9e-05	0.000389	CcSEcCtD
Ranolazine—Headache—Estradiol—prostate cancer	8.97e-05	0.000388	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—prostate cancer	8.96e-05	0.000387	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—prostate cancer	8.91e-05	0.000385	CcSEcCtD
Ranolazine—Angioedema—Prednisone—prostate cancer	8.9e-05	0.000385	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—prostate cancer	8.87e-05	0.000384	CcSEcCtD
Ranolazine—Urticaria—Etoposide—prostate cancer	8.82e-05	0.000381	CcSEcCtD
Ranolazine—Anorexia—Docetaxel—prostate cancer	8.79e-05	0.00038	CcSEcCtD
Ranolazine—Shock—Capecitabine—prostate cancer	8.78e-05	0.00038	CcSEcCtD
Ranolazine—Abdominal pain—Etoposide—prostate cancer	8.77e-05	0.000379	CcSEcCtD
Ranolazine—Nervous system disorder—Capecitabine—prostate cancer	8.76e-05	0.000379	CcSEcCtD
Ranolazine—Vertigo—Prednisone—prostate cancer	8.76e-05	0.000379	CcSEcCtD
Ranolazine—Thrombocytopenia—Capecitabine—prostate cancer	8.74e-05	0.000378	CcSEcCtD
Ranolazine—Syncope—Prednisone—prostate cancer	8.74e-05	0.000378	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—prostate cancer	8.71e-05	0.000377	CcSEcCtD
Ranolazine—Skin disorder—Capecitabine—prostate cancer	8.67e-05	0.000375	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—prostate cancer	8.65e-05	0.000374	CcSEcCtD
Ranolazine—Hyperhidrosis—Capecitabine—prostate cancer	8.63e-05	0.000373	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—prostate cancer	8.62e-05	0.000373	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—prostate cancer	8.62e-05	0.000373	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—prostate cancer	8.6e-05	0.000372	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—prostate cancer	8.6e-05	0.000372	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—prostate cancer	8.58e-05	0.000371	CcSEcCtD
Ranolazine—Loss of consciousness—Prednisone—prostate cancer	8.56e-05	0.00037	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—prostate cancer	8.51e-05	0.000368	CcSEcCtD
Ranolazine—Anorexia—Capecitabine—prostate cancer	8.51e-05	0.000368	CcSEcCtD
Ranolazine—Nausea—Estradiol—prostate cancer	8.5e-05	0.000368	CcSEcCtD
Ranolazine—Vomiting—Mitoxantrone—prostate cancer	8.48e-05	0.000367	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—prostate cancer	8.44e-05	0.000365	CcSEcCtD
Ranolazine—Rash—Mitoxantrone—prostate cancer	8.41e-05	0.000364	CcSEcCtD
Ranolazine—Dermatitis—Mitoxantrone—prostate cancer	8.4e-05	0.000363	CcSEcCtD
Ranolazine—Headache—Mitoxantrone—prostate cancer	8.36e-05	0.000361	CcSEcCtD
Ranolazine—Hypotension—Capecitabine—prostate cancer	8.34e-05	0.000361	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—prostate cancer	8.34e-05	0.000361	CcSEcCtD
Ranolazine—Propranolol—CYP3A4—prostate cancer	8.31e-05	0.016	CrCbGaD
Ranolazine—Paraesthesia—Docetaxel—prostate cancer	8.28e-05	0.000358	CcSEcCtD
Ranolazine—Anxiety—Prednisone—prostate cancer	8.27e-05	0.000357	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—prostate cancer	8.25e-05	0.000357	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.24e-05	0.000356	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—prostate cancer	8.22e-05	0.000355	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—prostate cancer	8.2e-05	0.000354	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—prostate cancer	8.18e-05	0.000354	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—prostate cancer	8.16e-05	0.000353	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—prostate cancer	8.13e-05	0.000351	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—prostate cancer	8.12e-05	0.000351	CcSEcCtD
Ranolazine—Insomnia—Capecitabine—prostate cancer	8.08e-05	0.000349	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—prostate cancer	8.06e-05	0.000348	CcSEcCtD
Ranolazine—Paraesthesia—Capecitabine—prostate cancer	8.02e-05	0.000347	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—prostate cancer	8.02e-05	0.000347	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—prostate cancer	8e-05	0.000346	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—prostate cancer	7.98e-05	0.000345	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—prostate cancer	7.96e-05	0.000344	CcSEcCtD
Ranolazine—Asthenia—Etoposide—prostate cancer	7.96e-05	0.000344	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—prostate cancer	7.96e-05	0.000344	CcSEcCtD
Ranolazine—Dyspnoea—Capecitabine—prostate cancer	7.96e-05	0.000344	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—prostate cancer	7.95e-05	0.000344	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—prostate cancer	7.94e-05	0.000343	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—prostate cancer	7.94e-05	0.000343	CcSEcCtD
Ranolazine—Nausea—Mitoxantrone—prostate cancer	7.92e-05	0.000343	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—prostate cancer	7.89e-05	0.000341	CcSEcCtD
Ranolazine—Constipation—Docetaxel—prostate cancer	7.89e-05	0.000341	CcSEcCtD
Ranolazine—Dyspepsia—Capecitabine—prostate cancer	7.86e-05	0.00034	CcSEcCtD
Ranolazine—Pruritus—Etoposide—prostate cancer	7.85e-05	0.000339	CcSEcCtD
Ranolazine—Shock—Prednisone—prostate cancer	7.82e-05	0.000338	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—prostate cancer	7.82e-05	0.000338	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—prostate cancer	7.81e-05	0.000338	CcSEcCtD
Ranolazine—Nervous system disorder—Prednisone—prostate cancer	7.8e-05	0.000337	CcSEcCtD
Ranolazine—Decreased appetite—Capecitabine—prostate cancer	7.76e-05	0.000336	CcSEcCtD
Ranolazine—Skin disorder—Prednisone—prostate cancer	7.72e-05	0.000334	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Capecitabine—prostate cancer	7.71e-05	0.000333	CcSEcCtD
Ranolazine—Fatigue—Capecitabine—prostate cancer	7.7e-05	0.000333	CcSEcCtD
Ranolazine—Hyperhidrosis—Prednisone—prostate cancer	7.69e-05	0.000332	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—prostate cancer	7.67e-05	0.000332	CcSEcCtD
Ranolazine—Constipation—Capecitabine—prostate cancer	7.64e-05	0.00033	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—prostate cancer	7.62e-05	0.00033	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—prostate cancer	7.6e-05	0.000329	CcSEcCtD
Ranolazine—Anorexia—Prednisone—prostate cancer	7.58e-05	0.000328	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—prostate cancer	7.57e-05	0.000327	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—prostate cancer	7.55e-05	0.000327	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—prostate cancer	7.54e-05	0.000326	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—prostate cancer	7.52e-05	0.000325	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—prostate cancer	7.51e-05	0.000325	CcSEcCtD
Ranolazine—Feeling abnormal—Capecitabine—prostate cancer	7.36e-05	0.000318	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—prostate cancer	7.35e-05	0.000318	CcSEcCtD
Ranolazine—Dizziness—Etoposide—prostate cancer	7.34e-05	0.000317	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—prostate cancer	7.33e-05	0.000317	CcSEcCtD
Ranolazine—Gastrointestinal pain—Capecitabine—prostate cancer	7.3e-05	0.000316	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—prostate cancer	7.3e-05	0.000316	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—prostate cancer	7.29e-05	0.000315	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—prostate cancer	7.24e-05	0.000313	CcSEcCtD
Ranolazine—Insomnia—Prednisone—prostate cancer	7.19e-05	0.000311	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—prostate cancer	7.18e-05	0.000311	CcSEcCtD
Ranolazine—Paraesthesia—Prednisone—prostate cancer	7.14e-05	0.000309	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—prostate cancer	7.1e-05	0.000307	CcSEcCtD
Ranolazine—Urticaria—Capecitabine—prostate cancer	7.09e-05	0.000307	CcSEcCtD
Ranolazine—Abdominal pain—Capecitabine—prostate cancer	7.06e-05	0.000305	CcSEcCtD
Ranolazine—Vomiting—Etoposide—prostate cancer	7.06e-05	0.000305	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—prostate cancer	7.05e-05	0.000305	CcSEcCtD
Ranolazine—Dyspepsia—Prednisone—prostate cancer	7e-05	0.000303	CcSEcCtD
Ranolazine—Rash—Etoposide—prostate cancer	7e-05	0.000303	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—prostate cancer	6.99e-05	0.000302	CcSEcCtD
Ranolazine—Headache—Etoposide—prostate cancer	6.95e-05	0.000301	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—prostate cancer	6.95e-05	0.0003	CcSEcCtD
Ranolazine—Decreased appetite—Prednisone—prostate cancer	6.91e-05	0.000299	CcSEcCtD
Ranolazine—Fatigue—Prednisone—prostate cancer	6.86e-05	0.000296	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—prostate cancer	6.85e-05	0.000296	CcSEcCtD
Ranolazine—Syncope—Epirubicin—prostate cancer	6.83e-05	0.000296	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—prostate cancer	6.82e-05	0.000295	CcSEcCtD
Ranolazine—Constipation—Prednisone—prostate cancer	6.8e-05	0.000294	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—prostate cancer	6.78e-05	0.000293	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—prostate cancer	6.74e-05	0.000291	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—prostate cancer	6.7e-05	0.00029	CcSEcCtD
Ranolazine—Cough—Epirubicin—prostate cancer	6.65e-05	0.000288	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—prostate cancer	6.65e-05	0.000287	CcSEcCtD
Ranolazine—Asthenia—Docetaxel—prostate cancer	6.62e-05	0.000286	CcSEcCtD
Ranolazine—Nausea—Etoposide—prostate cancer	6.59e-05	0.000285	CcSEcCtD
Ranolazine—Feeling abnormal—Prednisone—prostate cancer	6.55e-05	0.000283	CcSEcCtD
Ranolazine—Pruritus—Docetaxel—prostate cancer	6.52e-05	0.000282	CcSEcCtD
Ranolazine—Gastrointestinal pain—Prednisone—prostate cancer	6.5e-05	0.000281	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—prostate cancer	6.47e-05	0.00028	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.44e-05	0.000279	CcSEcCtD
Ranolazine—Asthenia—Capecitabine—prostate cancer	6.41e-05	0.000277	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—prostate cancer	6.35e-05	0.000274	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—prostate cancer	6.34e-05	0.000274	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—prostate cancer	6.32e-05	0.000273	CcSEcCtD
Ranolazine—Urticaria—Prednisone—prostate cancer	6.32e-05	0.000273	CcSEcCtD
Ranolazine—Pruritus—Capecitabine—prostate cancer	6.32e-05	0.000273	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—prostate cancer	6.31e-05	0.000273	CcSEcCtD
Ranolazine—Abdominal pain—Prednisone—prostate cancer	6.29e-05	0.000272	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—prostate cancer	6.27e-05	0.000271	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—prostate cancer	6.23e-05	0.000269	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—prostate cancer	6.2e-05	0.000268	CcSEcCtD
Ranolazine—Cough—Doxorubicin—prostate cancer	6.15e-05	0.000266	CcSEcCtD
Ranolazine—Shock—Epirubicin—prostate cancer	6.12e-05	0.000265	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—prostate cancer	6.1e-05	0.000264	CcSEcCtD
Ranolazine—Dizziness—Docetaxel—prostate cancer	6.1e-05	0.000264	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—prostate cancer	6.09e-05	0.000263	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—prostate cancer	6.04e-05	0.000261	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—prostate cancer	6.01e-05	0.00026	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—prostate cancer	5.98e-05	0.000259	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.96e-05	0.000258	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—prostate cancer	5.93e-05	0.000256	CcSEcCtD
Ranolazine—Dizziness—Capecitabine—prostate cancer	5.9e-05	0.000255	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—prostate cancer	5.87e-05	0.000254	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—prostate cancer	5.86e-05	0.000254	CcSEcCtD
Ranolazine—Rash—Docetaxel—prostate cancer	5.81e-05	0.000251	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—prostate cancer	5.81e-05	0.000251	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—prostate cancer	5.81e-05	0.000251	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—prostate cancer	5.8e-05	0.000251	CcSEcCtD
Ranolazine—Headache—Docetaxel—prostate cancer	5.78e-05	0.00025	CcSEcCtD
Ranolazine—Asthenia—Prednisone—prostate cancer	5.71e-05	0.000247	CcSEcCtD
Ranolazine—Vomiting—Capecitabine—prostate cancer	5.68e-05	0.000245	CcSEcCtD
Ranolazine—Shock—Doxorubicin—prostate cancer	5.66e-05	0.000245	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—prostate cancer	5.64e-05	0.000244	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—prostate cancer	5.64e-05	0.000244	CcSEcCtD
Ranolazine—Rash—Capecitabine—prostate cancer	5.63e-05	0.000243	CcSEcCtD
Ranolazine—Pruritus—Prednisone—prostate cancer	5.63e-05	0.000243	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—prostate cancer	5.63e-05	0.000243	CcSEcCtD
Ranolazine—Dermatitis—Capecitabine—prostate cancer	5.62e-05	0.000243	CcSEcCtD
Ranolazine—Headache—Capecitabine—prostate cancer	5.59e-05	0.000242	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—prostate cancer	5.59e-05	0.000242	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—prostate cancer	5.59e-05	0.000241	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—prostate cancer	5.56e-05	0.000241	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—prostate cancer	5.55e-05	0.00024	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—prostate cancer	5.53e-05	0.000239	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—prostate cancer	5.49e-05	0.000237	CcSEcCtD
Ranolazine—Nausea—Docetaxel—prostate cancer	5.48e-05	0.000237	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—prostate cancer	5.48e-05	0.000237	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—prostate cancer	5.41e-05	0.000234	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—prostate cancer	5.38e-05	0.000233	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—prostate cancer	5.37e-05	0.000232	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—prostate cancer	5.36e-05	0.000232	CcSEcCtD
Ranolazine—Constipation—Epirubicin—prostate cancer	5.32e-05	0.00023	CcSEcCtD
Ranolazine—Nausea—Capecitabine—prostate cancer	5.3e-05	0.000229	CcSEcCtD
Ranolazine—Dizziness—Prednisone—prostate cancer	5.26e-05	0.000227	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—prostate cancer	5.21e-05	0.000225	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—prostate cancer	5.17e-05	0.000223	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—prostate cancer	5.13e-05	0.000222	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—prostate cancer	5.13e-05	0.000222	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—prostate cancer	5.12e-05	0.000221	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—prostate cancer	5.09e-05	0.00022	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—prostate cancer	5.07e-05	0.000219	CcSEcCtD
Ranolazine—Vomiting—Prednisone—prostate cancer	5.06e-05	0.000219	CcSEcCtD
Ranolazine—Rash—Prednisone—prostate cancer	5.01e-05	0.000217	CcSEcCtD
Ranolazine—Dermatitis—Prednisone—prostate cancer	5.01e-05	0.000217	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—prostate cancer	5e-05	0.000216	CcSEcCtD
Ranolazine—Headache—Prednisone—prostate cancer	4.98e-05	0.000215	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.97e-05	0.000215	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—prostate cancer	4.96e-05	0.000215	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—prostate cancer	4.94e-05	0.000214	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—prostate cancer	4.92e-05	0.000213	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—prostate cancer	4.92e-05	0.000213	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—prostate cancer	4.74e-05	0.000205	CcSEcCtD
Ranolazine—Nausea—Prednisone—prostate cancer	4.72e-05	0.000204	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—prostate cancer	4.71e-05	0.000203	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—prostate cancer	4.57e-05	0.000198	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—prostate cancer	4.55e-05	0.000197	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—prostate cancer	4.46e-05	0.000193	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—prostate cancer	4.4e-05	0.00019	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—prostate cancer	4.13e-05	0.000179	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—prostate cancer	4.11e-05	0.000178	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—prostate cancer	4.07e-05	0.000176	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—prostate cancer	3.95e-05	0.000171	CcSEcCtD
Ranolazine—Rash—Epirubicin—prostate cancer	3.92e-05	0.00017	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—prostate cancer	3.92e-05	0.000169	CcSEcCtD
Ranolazine—Headache—Epirubicin—prostate cancer	3.9e-05	0.000168	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—prostate cancer	3.81e-05	0.000165	CcSEcCtD
Ranolazine—Nausea—Epirubicin—prostate cancer	3.69e-05	0.00016	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—prostate cancer	3.66e-05	0.000158	CcSEcCtD
Ranolazine—Rash—Doxorubicin—prostate cancer	3.63e-05	0.000157	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—prostate cancer	3.63e-05	0.000157	CcSEcCtD
Ranolazine—Headache—Doxorubicin—prostate cancer	3.61e-05	0.000156	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—prostate cancer	3.42e-05	0.000148	CcSEcCtD
Ranolazine—CYP2D6—Metabolism—HAO1—prostate cancer	3.34e-05	0.000442	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	3.34e-05	0.000442	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—NCOA2—prostate cancer	3.31e-05	0.000437	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP2—prostate cancer	3.25e-05	0.000429	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAP2K1—prostate cancer	3.24e-05	0.000429	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TGFB1—prostate cancer	3.23e-05	0.000427	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EGFR—prostate cancer	3.17e-05	0.000418	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—SRC—prostate cancer	3.15e-05	0.000417	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—FGF2—prostate cancer	3.08e-05	0.000408	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.08e-05	0.000408	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—prostate cancer	3.07e-05	0.000406	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.04e-05	0.000402	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KRAS—prostate cancer	2.99e-05	0.000395	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—JAK2—prostate cancer	2.96e-05	0.000391	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	2.92e-05	0.000386	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	2.88e-05	0.000381	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ERBB2—prostate cancer	2.84e-05	0.000376	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GGT1—prostate cancer	2.83e-05	0.000374	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.79e-05	0.000369	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EGFR—prostate cancer	2.76e-05	0.000365	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.75e-05	0.000363	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CSAD—prostate cancer	2.73e-05	0.00036	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PSAT1—prostate cancer	2.73e-05	0.00036	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADI1—prostate cancer	2.73e-05	0.00036	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TST—prostate cancer	2.73e-05	0.00036	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CBR1—prostate cancer	2.73e-05	0.00036	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GRHL1—prostate cancer	2.73e-05	0.00036	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.71e-05	0.000358	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.65e-05	0.000351	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KRAS—prostate cancer	2.61e-05	0.000345	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—COMT—prostate cancer	2.55e-05	0.000338	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.54e-05	0.000336	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UGT2B15—prostate cancer	2.53e-05	0.000335	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UGT2B17—prostate cancer	2.53e-05	0.000335	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CKMT2—prostate cancer	2.53e-05	0.000335	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GRHPR—prostate cancer	2.53e-05	0.000335	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.52e-05	0.000333	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.51e-05	0.000331	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CTNNB1—prostate cancer	2.49e-05	0.000329	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—prostate cancer	2.44e-05	0.000323	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—prostate cancer	2.43e-05	0.000322	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MBTPS1—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM3—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PGAM2—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—RFK—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AOX1—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NAGLU—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SULT2B1—prostate cancer	2.38e-05	0.000315	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.34e-05	0.000309	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EP300—prostate cancer	2.31e-05	0.000306	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.3e-05	0.000305	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NAT1—prostate cancer	2.26e-05	0.000299	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SRD5A2—prostate cancer	2.26e-05	0.000299	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP3A43—prostate cancer	2.26e-05	0.000299	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—DEGS1—prostate cancer	2.26e-05	0.000299	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AMACR—prostate cancer	2.26e-05	0.000299	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SRC—prostate cancer	2.25e-05	0.000297	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—prostate cancer	2.24e-05	0.000297	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.21e-05	0.000293	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—prostate cancer	2.19e-05	0.00029	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HAO1—prostate cancer	2.19e-05	0.000289	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.18e-05	0.000289	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—STAT3—prostate cancer	2.17e-05	0.000287	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD17B1—prostate cancer	2.15e-05	0.000285	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—prostate cancer	2.12e-05	0.000281	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TGFB1—prostate cancer	2.01e-05	0.000266	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EGFR—prostate cancer	1.97e-05	0.000261	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—B4GALT4—prostate cancer	1.92e-05	0.000254	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPGD—prostate cancer	1.92e-05	0.000254	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KRAS—prostate cancer	1.86e-05	0.000246	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TNFRSF21—prostate cancer	1.81e-05	0.000239	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CSAD—prostate cancer	1.78e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PSAT1—prostate cancer	1.78e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TST—prostate cancer	1.78e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CBR1—prostate cancer	1.78e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADI1—prostate cancer	1.78e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GRHL1—prostate cancer	1.78e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP7B1—prostate cancer	1.76e-05	0.000232	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTAP—prostate cancer	1.76e-05	0.000232	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SULT1E1—prostate cancer	1.71e-05	0.000226	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SRD5A1—prostate cancer	1.71e-05	0.000226	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.66e-05	0.000219	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CKMT2—prostate cancer	1.66e-05	0.000219	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.66e-05	0.000219	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GRHPR—prostate cancer	1.66e-05	0.000219	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ACSL4—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD17B3—prostate cancer	1.63e-05	0.000216	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ARG2—prostate cancer	1.57e-05	0.000207	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PHGDH—prostate cancer	1.57e-05	0.000207	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UMPS—prostate cancer	1.57e-05	0.000207	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AOX1—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—RFK—prostate cancer	1.56e-05	0.000206	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LDHB—prostate cancer	1.54e-05	0.000203	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—prostate cancer	1.52e-05	0.0002	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP3A5—prostate cancer	1.51e-05	0.000199	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.48e-05	0.000195	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AMACR—prostate cancer	1.48e-05	0.000195	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NAT1—prostate cancer	1.48e-05	0.000195	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.48e-05	0.000195	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.48e-05	0.000195	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA3—prostate cancer	1.46e-05	0.000192	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PDHA1—prostate cancer	1.46e-05	0.000192	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UCP3—prostate cancer	1.46e-05	0.000192	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TCN2—prostate cancer	1.46e-05	0.000192	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.41e-05	0.000186	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—prostate cancer	1.4e-05	0.000185	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD3B1—prostate cancer	1.39e-05	0.000184	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC22A3—prostate cancer	1.39e-05	0.000184	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA4—prostate cancer	1.33e-05	0.000176	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TBXAS1—prostate cancer	1.33e-05	0.000176	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA2—prostate cancer	1.3e-05	0.000171	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCG5—prostate cancer	1.28e-05	0.000169	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SULT1A1—prostate cancer	1.28e-05	0.000169	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPGD—prostate cancer	1.26e-05	0.000166	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.26e-05	0.000166	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA1—prostate cancer	1.25e-05	0.000165	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTO1—prostate cancer	1.24e-05	0.000164	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD3B2—prostate cancer	1.24e-05	0.000164	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NAT2—prostate cancer	1.24e-05	0.000164	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLCB2—prostate cancer	1.19e-05	0.000157	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LRP2—prostate cancer	1.19e-05	0.000157	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2C18—prostate cancer	1.19e-05	0.000157	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.18e-05	0.000156	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—P4HB—prostate cancer	1.16e-05	0.000154	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.15e-05	0.000152	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTAP—prostate cancer	1.15e-05	0.000152	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC22A1—prostate cancer	1.13e-05	0.00015	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.12e-05	0.000148	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.12e-05	0.000148	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SULT2A1—prostate cancer	1.1e-05	0.000146	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MED12—prostate cancer	1.09e-05	0.000143	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GNG5—prostate cancer	1.08e-05	0.000142	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ACSL4—prostate cancer	1.07e-05	0.000141	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.07e-05	0.000141	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA3—prostate cancer	1.04e-05	0.000137	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PHGDH—prostate cancer	1.02e-05	0.000135	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ARG2—prostate cancer	1.02e-05	0.000135	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UMPS—prostate cancer	1.02e-05	0.000135	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LDHB—prostate cancer	1e-05	0.000133	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPGDS—prostate cancer	9.89e-06	0.000131	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.85e-06	0.00013	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2C19—prostate cancer	9.83e-06	0.00013	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ACHE—prostate cancer	9.59e-06	0.000127	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTT1—prostate cancer	9.59e-06	0.000127	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TCN2—prostate cancer	9.51e-06	0.000126	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PDHA1—prostate cancer	9.51e-06	0.000126	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UCP3—prostate cancer	9.51e-06	0.000126	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA3—prostate cancer	9.51e-06	0.000126	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2A6—prostate cancer	9.48e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKR1C3—prostate cancer	9.23e-06	0.000122	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PRKACB—prostate cancer	9.18e-06	0.000121	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP17A1—prostate cancer	9.08e-06	0.00012	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.08e-06	0.00012	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.08e-06	0.00012	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.7e-06	0.000115	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA4—prostate cancer	8.7e-06	0.000115	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA2—prostate cancer	8.65e-06	0.000114	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA2—prostate cancer	8.48e-06	0.000112	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCG5—prostate cancer	8.38e-06	0.000111	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.38e-06	0.000111	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC5A5—prostate cancer	8.26e-06	0.000109	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA1—prostate cancer	8.18e-06	0.000108	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTO1—prostate cancer	8.09e-06	0.000107	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.09e-06	0.000107	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NAT2—prostate cancer	8.09e-06	0.000107	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2E1—prostate cancer	8.06e-06	0.000107	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NQO1—prostate cancer	7.97e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TH—prostate cancer	7.86e-06	0.000104	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP3A4—prostate cancer	7.78e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLCB2—prostate cancer	7.76e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.76e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LRP2—prostate cancer	7.76e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1B1—prostate cancer	7.64e-06	0.000101	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—P4HB—prostate cancer	7.61e-06	0.000101	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GGT1—prostate cancer	7.4e-06	9.79e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.4e-06	9.78e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA1—prostate cancer	7.29e-06	9.64e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.21e-06	9.53e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP19A1—prostate cancer	7.19e-06	9.5e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MED12—prostate cancer	7.09e-06	9.38e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GNG5—prostate cancer	7.04e-06	9.3e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—RXRA—prostate cancer	6.94e-06	9.17e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA3—prostate cancer	6.78e-06	8.96e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—COMT—prostate cancer	6.68e-06	8.83e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTP1—prostate cancer	6.65e-06	8.79e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ITPR1—prostate cancer	6.54e-06	8.65e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPGDS—prostate cancer	6.47e-06	8.55e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.43e-06	8.5e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ACHE—prostate cancer	6.27e-06	8.29e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTT1—prostate cancer	6.27e-06	8.29e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.2e-06	8.2e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TYMS—prostate cancer	6.18e-06	8.17e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM1—prostate cancer	6.11e-06	8.08e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.03e-06	7.97e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PRKACB—prostate cancer	6e-06	7.93e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LPL—prostate cancer	6e-06	7.93e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.94e-06	7.85e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A1—prostate cancer	5.79e-06	7.66e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ERCC2—prostate cancer	5.75e-06	7.6e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA2—prostate cancer	5.66e-06	7.48e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTHFR—prostate cancer	5.4e-06	7.14e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.4e-06	7.14e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARA—prostate cancer	5.3e-06	7e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.27e-06	6.97e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NQO1—prostate cancer	5.21e-06	6.89e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TH—prostate cancer	5.14e-06	6.79e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1B1—prostate cancer	5e-06	6.61e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CAV1—prostate cancer	4.98e-06	6.59e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GGT1—prostate cancer	4.84e-06	6.4e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA1—prostate cancer	4.77e-06	6.3e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.7e-06	6.21e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CG—prostate cancer	4.54e-06	6e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—RXRA—prostate cancer	4.54e-06	5.99e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—COMT—prostate cancer	4.37e-06	5.77e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTP1—prostate cancer	4.35e-06	5.75e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—INS—prostate cancer	4.3e-06	5.68e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ITPR1—prostate cancer	4.28e-06	5.66e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CREBBP—prostate cancer	4.21e-06	5.56e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TYMS—prostate cancer	4.04e-06	5.34e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM1—prostate cancer	4e-06	5.28e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CD—prostate cancer	3.99e-06	5.27e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LPL—prostate cancer	3.92e-06	5.18e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.79e-06	5.01e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NOS3—prostate cancer	3.77e-06	4.98e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ERCC2—prostate cancer	3.76e-06	4.97e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTHFR—prostate cancer	3.53e-06	4.67e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CB—prostate cancer	3.48e-06	4.6e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARA—prostate cancer	3.46e-06	4.58e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS2—prostate cancer	3.45e-06	4.55e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CAV1—prostate cancer	3.26e-06	4.31e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTEN—prostate cancer	3e-06	3.97e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.97e-06	3.92e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—EP300—prostate cancer	2.87e-06	3.79e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—INS—prostate cancer	2.81e-06	3.71e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CREBBP—prostate cancer	2.75e-06	3.64e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.61e-06	3.45e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NOS3—prostate cancer	2.46e-06	3.26e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.27e-06	3.01e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.12e-06	2.8e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTEN—prostate cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—EP300—prostate cancer	1.87e-06	2.48e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—prostate cancer	1.73e-06	2.29e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.39e-06	1.83e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—prostate cancer	1.13e-06	1.5e-05	CbGpPWpGaD
